Russian Medical Inquiry
(RMZh. Meditsinskoe Obozrenie) ISSN 2587-6821 (Print), 2686-9918 (Online)

Iron-deficiency anemia: a view of hematologist and gynecologist. Optimizing diagnostic and treatment approach

VAK

Scopus

E-libraryDimensions

russian citation indexULRICHS

roaddoaj

CyberleninkaGoogle Scholar

vinitiResearch4life

MendeleyScilit

РГБWhite list




Open accessCrossrefAntiplagiat

RMJ.ru




DOI: 10.32364/2618-8430-2020-3-4-248-253

E.A. Lukina1, A.V. Ledina2,3,4, S.I. Rogovskaya3

1National Medical Research Center of Hematology, Moscow, Russian Federation

2Russian University of Peoples’ Friendship, Moscow, Russian Federation

3Russian Association of Genital Infections & Neoplasia, Moscow, Russian Federation

4Lapino Clinical Hospital “Mother & Child”, Moscow region, Russian Federation

Iron-deficiency anemia (IDA) is an acquired disease characterized by the reduced levels of iron in the serum, tissues, and bone marrow that mainly result from hemorrhages (e.g., nasal, gastrointestinal etc.). Women are at risk for IDA due to the physiological monthly loss of blood, childbearing, and breastfeeding but also due to various gynecological disorders leading to iron depletion and anemia. The paper describes the pathogenic mechanisms, diagnostic criteria, and clinical presentations of IDA and the potential consequences of iron overload. Considering a high medical and social importance of anemia in pregnancy, the data on IDA prevalence in this cohort as well as the potential complications both for the mother and the child are addressed. Current therapeutic approaches for anemia using peroral and parenteral iron preparations and their indications are highlighted. The prevention of iron deficiency and the effective options of its correction are viable tasks which allow f or improving the health and quality of women’s life.

Keywords: anemia, iron-deficiency anemia, diagnosis, pregnancy, latent iron deficiency, iron overload, treatment, iron (II) fumarate.

For citation: Lukina E.A., Ledina A.V., Rogovskaya S.I. Iron-deficiency anemia: a view of hematologist and gynecologist. Optimizing diagnostic and treatment approach. Russian Journal of Woman and Child Health. 2020;3(4):248–253. DOI: 10.32364/2618-8430-2020-3-4-248-253.

References
1. Kumari R., Bharti R.K., Singh K. et al. Prevalence of iron deficiency and iron deficiency anaemia in adolescent girls in a tertiary care hospital. J Clin Diagn Res. 2017;11(8): BC04-BC06. DOI: 10.7860/JCDR/2017/26163.10325.
2. Chaparro C.M., Suchdev P.S. Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries. Ann N Y Acad Sci. 2019;1450(1):15–31. DOI: 10.1111/nyas.14092.
3. World Health Organization. The global prevalence of anaemia in 2011. Geneva (Switzerland): WHO; 2015.
4. United Nations Children’s Fund, United Nations University, World Health Organization. Iron deficiency anemia: assessment, prevention and control. A guide for programme managers. 2001.
5. Idelson L.I., Vorobiev P.A. Iron deficiency anemia. In: Guide to Hematology. A.I. Vorobiev, ed. Vol. 3. M.: Newdiamed; 2005.
6. Vorobiev A.I. Rational pharmacotherapy of diseases of the blood system. M.: Litera; 2009.
7. Camaschella C. Iron deficiency. Blood. 2019;133:30–39. DOI: 10.1182/blood-2018-05-815944.
8. Breymann C., Auerbach M. Iron deficiency in gynecology and obstetrics: clinical implications and management. Hematology Am Soc Hematol Educ Program. 2017;2017(1):152–159. DOI: 10.1182/asheducation-2017.1.152.
9. Сappellini M.D., Musallam K.M., Taher A.T. Iron deficiency anaemia revisited. J Intern Med. 2020;287(2):153–170. DOI: 10.1111/joim.13004.
10. Kohgo Y., Ikuta K., Ohtake T. et al. Body iron metabolism and pathophysiology of iron overload. Int J Hematol. 2008;88(1):7–15. DOI: 10.1007/s12185-008-0120-5.
11. Imam M.U., Zhang S., Ma J. et al. Antioxidants Mediate Both Iron Homeostasis and Oxidative Stress. Nutrients. 2017;9(7):671. DOI: 10.3390/nu9070671.
12. Lukina E.A., Dezhenkova A.V. Iron Metabolism in Normal and Pathological Conditions. Clinical oncohematology. 2015;8(4):355–361 (in Russ.). DOI: 10.21320/2500-2139-2015-8-4-362-367.
13. Lukina E.A., Smetanina N.S., Tsvetaeva N.V. and other National clinical guidelines. Iron overload: diagnosis and treatment. 2018.
14. Lima T.G., Benevides F.L.N., Esmeraldo Filho F.L. et al. Treatment of iron overload syndrome: a general review. Rev Assoc Med Bras (1992). 2019;65(9):1216–1222. DOI: 10.1590/1806-9282.65.9.1216.
15. Anderson G.J., Frazer D.M. Current understanding of iron homeostasis. Am J Clin Nutr. 2017;106(Suppl 6):1559S–1566S. DOI: 10.3945/ajcn.117.155804.
16. Gafter-Gvili A., Schechter A., Rozen-Zvi B. Iron Deficiency Anemia in Chronic Kidney Disease. Acta Haematol. 2019;142(1):44–50. DOI: 10.1159/000496492.
17. Means R.T., Krantz S.B. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood. 1992;80:1639–1647. DOI: 10.1182/blood.V80.7.1639.1639.
18. Camaschella C., Nai A., Silvestri L. Iron metabolism and iron disorders revisited in the hepcidin era. Haematologica. 2020;105(2):260–272. DOI: 10.3324/haematol.2019.232124.
19. Lopez A., Cacoub P., Macdougall I.C., Peyrin-Biroulet L. Iron deficiency anaemia. Lancet. 2016;387(10021):907–916. DOI: 10.1016/S0140-6736 (15) 60865-0.
20. Stuklov N.I. Ferrodeficiency syndromes in questions and answers. Iron deficiency, anemia and pregnancy: a hematologist’s view. Status Praesens. 2017;5(42):136–140 (in Russ.).
21. Balashova E.A., Mazur L.I., Tezikov Yu.V., Lipatov I.S. The impact of iron deficiency correction in pregnant women on the perinatal period and children’s health status. Russian Bulletin of Perinatology and Pediatrics. 2020;65(1):51–58 (in Russ.). DOI: 10.21508/1027-4065-2020-65-1-51-58.
22. Bencaiova G., Burkhardt T., Breymann C. Anemia-prevalence and risk factors in pregnancy. Eur J Intern Med. 2012;23(6):529–533. DOI: 10.1016/j.ejim.2012.04.008.
23. Milman N., Taylor C.L., Merkel J., Brannon P.M. Iron status in pregnant women and women of reproductive age in Europe. Am J Clin Nutr. 2017;106(Suppl 6):1655S–1662S. DOI: 10.3945/ajcn.117.156000.
24. Tyutyunnik V.L., Kan N.E., Lomova N.A., Dokueva R.S. Iron deficiency conditions in pregnant women and puerperas. Medical Council. 2017;(13):58–62 (in Russ.). DOI: 10.21518/2079-701X-2017-13-58-62.
25. Radzinsky V.E., Ryabinkina T.S. Iron deficiency anemia in pregnant women: risks and opportunities for correction. StatusPraesens. 2017;2(38):1–8 (in Russ.).
26. Dvoretsky L.I. Anemia: strategy and tactics of diagnostic search. Spravochnik poliklinicheskogo vracha. 2002;6:5–10 (in Russ.).
27. Auerbach M., Adamson J.W. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016;91(1):31–38. DOI: 10.1002/ajh.24201.
28. Allen R.P., Auerbach S., Bahrain H. et al. The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia. Am J Hematol. 2013;88(4):261–264. DOI: 10.1002/ajh.23397.
29. Allen R.P., Picchietti D.L., Auerbach M. et al. Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. Seep Med. 2018;41:27–44. DOI: 10.1016/j.sleep.2017.11.1126.
30. Maggini S., Pierre A., Calder P.C. Immune function and micronutrient requirements change over the life course. Nutrients. 2018;10(10):1531. DOI: 10.3390/nu10101531.
31. Pogorelov V.M., Kozinets G.I., Kovaleva L.G. Laboratory and clinical diagnostics of anemias. M.: Medical Information Agency; 2004 (in Russ.).
32. Dolgov V.V., Lugovskaya S.A., Morozova V.T., Pochtar’ M.E. Laboratory diagnostics of anemias. Tver: LLC Provincial Medicine; 2001 (in Russ.).
33. Moretti D., Goede J.S., Zeder C. et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015;126(17):1981–1989. DOI: 10.1182/blood-2015-05-642223.
34. Stoffel N.U., Cercamondi C.I., Brittenham G. et al. Iron absorption from oral iron supple-ments given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron- depleted women: two open-label, randomised controlled trials. Lancet Haematol. 2017;4(11): e524–e533. DOI: 10.1016/S2352-3026 (17) 30182-5.
35. Jaeggi T., Kortman G.A., Moretti D. et al. Iron fortification adversely affects the gut micro- biome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut. 2015;64(5):731–742. DOI: 10.1136/gutjnl-2014-307720.
36. Torshin I.Y., Gromova O.A., Limanova O.A. A meta-analysis of clinical studies on the use of iron fumarate for the prevention and treatment of iron deficiency anemia in pregnant women. Gynecology. 2015;17(5):24–31 (in Russ.).
37. Baev O.R. Prevention and treatment of iron deficiency conditions during pregnancy: the use of a combination of iron and folic acid. Pharmateca. 2011;13:47–52 (in Russ.).

License Creative Commons
This work is licensed under a Creative Commons «Attribution» 4.0 License.


Previous article
Next article